The FOXO3a transcription factor is a target of cell survival and proliferative signaling by the NPM-ALK fusion kinase of anaplastic large cell lymphoma.

被引:0
|
作者
Sternberg, DW
Gu, TL
Tothova, Z
Scheijen, B
Griffin, JD
Gilliland, DG
机构
[1] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
78
引用
收藏
页码:25A / 25A
页数:1
相关论文
共 50 条
  • [31] Involvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK+ anaplastic large cell lymphoma
    Hu, Linlin
    Zhang, Xiaonan
    Wang, Jian
    Wang, Song
    Amin, Hesham M.
    Shi, Ping
    HEMATOLOGY, 2018, 23 (05) : 284 - 290
  • [32] NPM-ALK activates c-jun n-terminal kinase (JNK) in anaplastic large cell lymphoma
    Leventaki, V.
    Drakos, E.
    Lim, M.
    Vidaki, A.
    Elenitoba-Johnson, K. S. J.
    Claret, F. X.
    Medeiros, L. J.
    Rassidakis, G. Z.
    LABORATORY INVESTIGATION, 2007, 87 : 250A - 250A
  • [33] ALK signaling and target therapy in anaplastic large cell lymphoma
    Tabbo, Fabrizio
    Barreca, Antonella
    Piva, Roberto
    Inghirami, Giorgio
    FRONTIERS IN ONCOLOGY, 2012, 2
  • [34] NPM-ALK activates c-jun n-terminal kinase (JNK) in anaplastic large cell lymphoma
    Leventaki, V.
    Drakos, E.
    Lim, M.
    Vidaki, A.
    Elenitoba-Johnson, K. S. J.
    Claret, F. X.
    Medeiros, L. J.
    Rassidakis, G. Z.
    MODERN PATHOLOGY, 2007, 20 : 250A - 250A
  • [35] IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
    Shi, Ping
    Lai, Raymond
    Lin, Quan
    Iqbal, Abid S.
    Young, Leah C.
    Kwak, Larry W.
    Ford, Richard J.
    Amin, Hesham M.
    BLOOD, 2009, 114 (02) : 360 - 370
  • [36] Design and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL)
    Ritter, U
    Damm-Welk, C
    Fuchs, U
    Bohle, RM
    Borkhardt, A
    Woessmann, W
    OLIGONUCLEOTIDES, 2003, 13 (05) : 365 - 373
  • [37] IDENTIFICATION AND DIAGNOSTIC APPLICATION OF GENOMIC NPM-ALK FUSION SEQUENCES IN ANAPLASTIC LARGE CELL LYMPHOMAS
    Krumbholz, M.
    Damm-Welk, C.
    Woessmann, W.
    Metzler, M.
    HAEMATOLOGICA, 2017, 102 : 571 - 571
  • [38] Cell proliferation induced by the NPM-ALK fusion tyrosine kinase of anaplastic large cell lymphoma is mediated by mTOR/S6K1 and MEK/ERK signaling.
    Amaravadi, RK
    Haq, N
    Morris, SW
    Gilliland, DG
    Sternberg, DW
    BLOOD, 2004, 104 (11) : 73A - 73A
  • [39] Arsenic trioxide downregulates NPM-ALK and inhibits the proliferation of ALK-positive anaplastic large cell lymphoma
    Piao, Wenying
    Chau, David H. W.
    Yue, Kevin L. M.
    Kwong, Yok Lam
    Tse, Eric W. C.
    CANCER RESEARCH, 2015, 75
  • [40] Hammerhead ribozyme-mediated cleavage of the fusion transcript NPM-ALK associated with anaplastic large-cell lymphoma
    Hübinger, G
    Wehnes, E
    Xue, L
    Morris, SW
    Maurer, U
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (03) : 226 - 233